Does Turmeric Cure or Prevent Cancer?

Turmeric is a plant in the ginger family, grown in India and Southeast Asia. Ground from its root, it turns curry yellow. Its best known compound is curcumin. That is what gives the spice its color.

This page is messier than most claim checks. Turmeric is not in the class of baking soda or laetrile. Real trials exist, and some early findings are interesting. There are also problems the ads never mention, including a liver risk that surfaced only recently.

The National Center for Complementary and Integrative Health is part of the National Institutes of Health. It tracks this work. Its bottom line fits in one sentence: "We don't know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes."

That covers arthritis, fatty liver disease, high cholesterol, depression, allergies, and itching. All have been studied. None are settled. On arthritis, NCCIH calls the early evidence positive but says better studies are needed.

The one cancer note is narrower than the headlines suggest. Turmeric "might improve symptoms of oral mucositis." That is the swelling and sores inside the mouth that some cancer treatments cause. Easing a side effect is not treating a tumor.

On cancer itself, NCCIH is blunt: "No complementary health approach has been shown to prevent or cure cancer."

Most articles note that curcumin is hard to absorb, then move on. The numbers deserve a look.

Bioavailability means how much of a substance reaches your blood in a usable form. In 2017, Nelson and colleagues reviewed curcumin in the Journal of Medicinal Chemistry. They put its oral bioavailability in rats at less than 1%. In human studies, curcumin could not be found in the blood of most people who took it, even at the highest tolerated doses.

Curcumin is also unstable. In water at neutral acidity, half of it breaks down in about 20 minutes. At body heat, faster.

So a lab study may report that curcumin killed cancer cells at some level. The fair next question is whether a person could ever reach that level by swallowing it. Usually the answer is no.

There is a second problem, and it is less well known.

Chemists have a category called PAINS. It is short for pan-assay interference compounds. These molecules look active in almost every lab test. They score well not because they do anything useful, but because they disturb the test itself.

The Nelson review argues that curcumin shows "all known PAINS-type behaviors." The list includes binding to proteins, grabbing metals, breaking apart, and glowing under the light used to read many tests. The advice to other scientists is direct. Any report of curcumin activity that does not rule out these effects "should be treated with caution."

The authors coined a phrase for compounds like this: an invalid metabolic panacea. A substance that seems to do everything usually does nothing in particular.

Their sharpest line is about results. To their knowledge, curcumin "has never been shown to be conclusively effective in a randomized, placebo-controlled clinical trial for any indication."

Small studies have been done, and Memorial Sloan Kettering's About Herbs database lists them.

In advanced pancreatic cancer, a phase II trial reported "clinically relevant biological activity in two patients despite limited absorption." Two patients. In prostate cancer, a blend with curcumin slowed the rise of PSA after treatment. In advanced colorectal cancer, curcumin was safe alongside FOLFOX chemotherapy. In head and neck cancer it helped appetite and weight loss. In breast cancer, early work suggests better quality of life and less joint pain.

Read that list again and notice the pattern. Where curcumin looks useful, it is as supportive care. Mouth sores, skin irritation from radiation, appetite, joint aches. Those matter. But they are not tumor shrinkage, and no trial has shown it helps people live longer.

The absorption problem was obvious, so makers engineered around it. Some added piperine, the active compound in black pepper. Others packed curcumin into tiny fat particles. These "high bioavailability" versions do get more curcumin into the blood.

They also started sending people to the hospital.

LiverTox is the NIH database of liver injury caused by drugs. It now rates turmeric with a likelihood score of A. That is its top category: an established cause of visible liver injury. The better-absorbed products, it says, "were subsequently linked to several cases of liver injury."

The details matter if you take these products. Injury usually shows up one to four months after starting. In some cases it took as long as eight months. The damage is hepatocellular, meaning it hits liver cells directly. Liver enzyme levels are often above 1,000 units per liter. A 2023 report from the Drug-Induced Liver Injury Network described ten cases seen between 2011 and 2022. One patient died. Among people who turn jaundiced from it, LiverTox estimates about 10% of cases may be fatal.

There is a genetic thread too. A gene variant called HLA-B*35:01 turned up in about 70% of these liver injury cases. In control groups it was found in 10% to 15%. Almost nobody knows whether they carry it.

NCCIH gives the same warning in plainer terms. It lists what to watch for: fatigue, nausea, poor appetite, dark urine, or jaundice. Jaundice means a yellow tint in the skin or eyes.

The irony is sharp. The fix for curcumin's biggest weakness created its biggest danger.

If you are in active treatment, bring this section to your oncologist.

MSK lists lab findings that point the wrong way. In breast cancer cells, turmeric blocked the killing effect of three chemotherapy drugs: doxorubicin, camptothecin, and mechlorethamine. In animals, turmeric in the diet blocked tumor shrinkage from cyclophosphamide. These are lab and animal results, not proof of harm in people. But they argue for caution, not optimism.

Curcumin also blocks liver enzymes that process medicines. Three of them are CYP3A4, CYP1A2, and CYP2D6. Many cancer drugs are broken down by those enzymes. Block them and drug levels in the blood can shift either way. Turmeric also raises bleeding risk with blood thinners. MSK notes a death after curcumin was given by vein, a route no one should be using.

NCCIH sums up the general risk: "some herbs may make chemotherapy drugs less effective."

Cooking with turmeric is fine. Kitchen amounts have a long safety record.

Supplements are a different product with different risks. If you are thinking about one, tell your oncology team before you start. Name the brand. Say whether it contains piperine or claims better absorption, since those are the forms tied to liver injury.

Keep the claim in proportion. Curcumin is a live research area with real supportive-care findings. NCI's verdict covers this whole territory: "there is no proof that any nutrition trend, food, vitamin, mineral, dietary supplement, herb, or combination of these can slow cancer, cure it, or keep it from coming back."

• https://www.nccih.nih.gov/health/turmeric
• https://www.nccih.nih.gov/health/cancer-and-complementary-health-approaches-what-you-need-to-know
• https://www.ncbi.nlm.nih.gov/books/NBK548561/
• https://pmc.ncbi.nlm.nih.gov/articles/PMC5346970/
• https://www.mskcc.org/cancer-care/integrative-medicine/herbs/turmeric
• https://www.cancer.gov/about-cancer/treatment/cam/diets-supplements